Clinigen Group (CLIN)

 

CLIN Share PerformanceMore

52 week high1,175.0 06/10/17
52 week low695.0 09/11/16
52 week change 363.0 (47.64%)
4 week volume10,061,843 23/09/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Form 8.3 - Clinigen Group Plc

Opening position disclosure/dealing disclosure by a person with interests in relevant securities representing 1% or more

Form 8.3 - QP LN/CLIN LN

RNS Number: 1018U Syquant Capital 19 October 2017 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Identity of the person whose positions/dealings are bein...

Form 8.3 - CLIN LN/QP LN

RNS Number: 1017U Syquant Capital 19 October 2017 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Identity of the person whose positions/dealings are bein...

Form 8.3 - Clinigen Group plc

RNS Number: 0848U BlackRock Group 19 October 2017 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: BlackRock, Inc. (b) Owner or...

Form 8.3 - [Clinigen Group plc]

RNS Number: 1164U Schroders PLC 19 October 2017 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: Schroders plc (b) Owner or contr...

Form 8.3 - Clinigen Group Plc

RNS Number: 1073U MVN Asset Management Limited 19 October 2017 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: MVN Asset M...

Form 8.3 - Clinigen Group plc

RNS Number: 0871U Janus Henderson Investors 19 October 2017 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: Janus Henderson Gr...

Form 8.3 - Clinigen Group plc

RNS Number: 0763U Tudor Capital Europe LLP 19 October 2017 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: Tudor Capital Euro...

Fundamental DataMore

P/E ratio340.909
EPS3.3
Dividend yield0.444 %

Latest discussion posts More

  • Cuurent Price

    With the price increasing toward the #11 recently due to the purchasing of Quantum Pharma I have decided to sell my shares today after several years of holding. I feel the ...
    21-Aug-2017
    bushwhacker
  • Re: Quantum Pharma

    From MoneyAM: Quantum Pharma plc is a growing manufacturer, supplier and service provider within the pharmaceutical sector. It is a market leader (in terms of its size or ...
    16-Aug-2017
    MaX ProfOrdiS
  • Quantum Pharma

    Does anyone know anything about Quantum Pharma? Clinigien proposed bid for the comapnay
    16-Aug-2017
    bushwhacker

Users' HoldingsMore

Users who hold Clinigen Group also hold..
LLOYDS GRP.21%
TELFORD HOMES18%
GLAXOSMITHKLINE17%
BP16%
RDS 'B'16%

Codes & Symbols

ISINGB00B89J2419
SymbolsCLIN, LSE:CLIN, CLIN.L, CLIN:LN, LON:CLIN, XLON:CLIN